SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 5, 1996
Xechem International, Inc.
(Exact name of Registrant as Specified in its Charter)
Delaware 0-23788 22-3284803
(State of Incorporation) (Commission File No.) (IRS Employer Identification No.)
100 Jersey Avenue, Bldg. B, #310
New Brunswick, N.J. 08901
(Address of Principal Executive Offices)
Registrant's telephone number, including area code: (908) 247-3300
1
<PAGE>
Item 5. Other Events
On February 4, 1997, Xechem International, Inc. (the "Company") received
notice after close of business from the Nasdaq Stock Market ("Nasdaq") that the
Company's common stock and warrants have been delisted from further trading on
Nasdaq effective at the close of business on February 4, 1997. The Company has
not yet determined whether it will appeal the hearing panel's decision. The
Company is also investigating the possibility of listing its common stock and
warrants on a regional stock exchange. Subsequent to such delisting, the Company
expects that trading for both the Company's common stock and warrants will be
conducted on the OTC Bulletin Board or in the over-the-counter market on what is
commonly referred to as the "pink sheets".
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Xechem International, Inc.
By: /s/ Ramesh C. Pandey
Dr. Ramesh C. Pandey, President and Chief
Executive Officer
Dated: February 10, 1997
3
<PAGE>
